Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a ...
Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...
Louisville Public Media on MSN2h
His genes forecast Alzheimer's. His brain had other plans.Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback